Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Aricept
Active Ingredient: Donepezil hydrochloride 10mg equivalent to 9.12mg donepezil free base
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer PGM, Zone Industrielle, Poce Sur Cisse, France
Product: Aricept
Active Ingredient: Donepezil hydrochloride 5mg equivalent to 4.56mg donepezil free base
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer PGM, Zone Industrielle, Poce Sur Cisse, France
Product: Aricept-D
Active Ingredient: Donepezil hydrochloride 10mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Eisai Co Limited, Hiroki, Ohaza, Misato-machi, Kodama-gun, Saitama-ken, Japan
Product: Aricept-D
Active Ingredient: Donepezil hydrochloride 5mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Eisai Co Limited, Hiroki, Ohaza, Misato-machi, Kodama-gun, Saitama-ken, Japan
Product: Daivobet
Active Ingredients: Betamethasone dipropionate 643µg/g equivalent to 500µg/g betamethasone
Calcipotriol 50µg/g
Dosage Form: Topical ointment
New Zealand Sponsor: CSL Biotherapies (NZ) Limited
Manufacturer: Leo Laboratories Limited, Crumlin, Dublin, Ireland
Dated this 22nd day of March 2007.
CYNTHIA MALING, Acting-Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).